M
TEVA icon

MOTCO’s Teva Pharmaceuticals TEVA Stock Holding History

MOTCO’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-695
Closed -$6K – 734
2020
Q1 		$6K Hold
695
– – ﹤0.01% 482
2019
Q4 		$7K Sell
695
-3,305
-83% -$29.5K ﹤0.01% 457
2019
Q3 		$28K Buy
+4,000
New +$30.6K ﹤0.01% 360
2018
Q3 		– Sell
-1,000
Closed -$24K – 577
2018
Q2 		$24K Buy
+1,000
New +$20.4K ﹤0.01% 378
2013
Q4 		– Sell
-880
Closed -$33K – 598
2013
Q3 		$33K Hold
880
– – ﹤0.01% 338
2013
Q2 		$34K Buy
+880
New +$34.3K ﹤0.01% 341

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MOTCO's TEVA Position: Q2 2020 in Review

MOTCO sold out of Teva Pharmaceuticals (TEVA) in Q2 2020, closing a stake of 695 shares — an estimated $6K sold.

MOTCO first reported a position in TEVA in Q2 2013 and held it in 6 quarters. The position peaked at $34K in Q2 2013. 455 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • MOTCO reported no remaining Teva Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • MOTCO sold 695 Teva Pharmaceuticals shares in Q2 2020, an estimated $6K.
  • MOTCO first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • MOTCO's Teva Pharmaceuticals position peaked at $34K in Q2 2013.
  • 455 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on MOTCO's 13F filing for Q2 2020, filed 15 Jul 2020.